Glaxosmithkline plc - FDA Panel Recommends 2 RSV Vaccines for Older Adults
The shots, if approved by the agency, would be the first vaccines publicly available against a respiratory virus that kills thousands a year. Some advisers did cite a small but...
View ArticleGlaxosmithkline plc - FDA Panel Backs GSK's RSV Vaccine for Older People
GSK Plc's vaccine for respiratory syncytial virus won the support of a key panel of U.S. regulatory advisers for use in people aged 60 and older, as the drugmaker races against...
View ArticleGlaxosmithkline plc - Owlstone Medical Enters Partnership with Bicycle...
Owlstone Medical, the global leader in Breath Biopsy® announced that it has entered into a Research Agreement with Bicycle Therapeutics plc.
View ArticleGlaxosmithkline plc - Perrigo Announces Voluntary Recall of Limited Quantity...
Perrigo Company plc is issuing a voluntary recall of certain lots of Gerber® Good Start® SootheProTM Powdered Infant Formula in the U.S., that were manufactured at the...
View ArticleGlaxosmithkline plc - Philadelphia Water Supply Chemical Spill Prompts Advisory
More than 8,000 gallons of an acrylic polymer solution leaked on Friday into a tributary of the Delaware River, a source of the city's drinking water.
View ArticleGlaxosmithkline plc - Avacta appoints Karen Harrison as Chief Operating...
Avacta Group plc today announced the appointment of Karen Harrison as Chief Operating Officer of its Therapeutics Division.
View ArticleGlaxosmithkline plc - AstraZeneca's Covid Vaccine May Have Posed a Higher...
A new analysis examined deaths in Britain, where the company's product was restricted in 2021 because of safety concerns.
View ArticleGlaxosmithkline plc - Big pharma wants YOUR NHS data: GSK boss begs Rishi...
Speaking at a conference in London yesterday, Dame Emma Walmsley, chief executive of GlaxoSmithKline, urged Rishi Sunak to 'keep pushing' his team 'to do more'.
View ArticleGlaxosmithkline plc - British Man Died of Rare Blood Syndrome Linked to...
One expert said the blood-clotting syndrome was estimated to occur in one in 50,000 people under 40 and one in 100,000 over 40 who received AstraZeneca's vaccine.
View Article
